We are live on
!
Find out more
BG
BlackRock Group Portfolio holdings
AUM
$210B
1-Year Est. Return
15.5%
This Fund
S&P 500
This Quarter
Est. Return
+1.81%
1 Year Est. Return
+15.5%
3 Year Est. Return
+34.5%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$186B
AUM Growth
-$1.28B
(-0.68%)
Cap. Flow
-$2.98B
Cap. Flow
% of AUM
-1.6%
Top 10 Holdings %
Top 10 Hldgs %
14.29%
Holding
2,978
New
110
Increased
1,386
Reduced
1,151
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$296M |
| 2 |
AGN
Allergan plc
AGN
|
+$253M |
| 3 |
Walmart Inc
WMT
|
+$120M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$107M |
| 5 |
MBLY
Mobileye N.V.
MBLY
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$591M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$410M |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$161M |
| 4 |
Freeport-McMoran
FCX
|
+$147M |
| 5 |
Pfizer
PFE
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.86% |
| 2 | Financials | 13.96% |
| 3 | Technology | 13.7% |
| 4 | Industrials | 8.79% |
| 5 | Communication Services | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Merit Medical Systems
MMSI
$4.56B
| $6.49M | ﹤0.01% |
336,972
-333,789
| -50% | -$5.95M |
|
|
ANAC
1052
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $6.48M | ﹤0.01% |
111,964
+17,047
| +18% | +$724K |
|
1053
BWX Technologies
BWXT
$16B
| $6.42M | ﹤0.01% |
279,635
-378,317
| -57% | -$7.95M |
|
1054
OSI Systems
OSIS
$3.53B
| $6.39M | ﹤0.01% |
86,115
-3,856
| -4% | -$276K |
|
|
GREK
1055
Global X MSCI Greece ETF
GREK
$291M
| $6.34M | ﹤0.01% |
+191,882
| New | +$6.99M |
|
|
SCTY
1056
DELISTED
SolarCity Corporation
SCTY
| $6.3M | ﹤0.01% |
122,923
+10,368
| +9% | +$532K |
|
1057
Idexx Laboratories
IDXX
$44B
| $6.23M | ﹤0.01% |
80,704
-26,660
| -25% | -$2.07M |
|
1058
Sabesp
SBS
$19.8B
| $6.21M | ﹤0.01% |
5,905,291
-2,059,979
| -26% | -$2.21M |
|
|
CSR
1059
Centerspace
CSR
$943M
| $6.19M | ﹤0.01% |
82,495
-1,962
| -2% | -$155K |
|
|
TGI
1060
DELISTED
Triumph Group
TGI
| $6.12M | ﹤0.01% |
102,463
+3,229
| +3% | +$194K |
|
|
AVIV
1061
DELISTED
AVIV REIT INC COM STK (MD)
AVIV
| $6.1M | ﹤0.01% |
167,181
-15,116
| -8% | -$560K |
|
|
AD
1062
Array Digital Infrastructure
AD
$3.02B
| $6.09M | ﹤0.01% |
170,528
+10,472
| +7% | +$383K |
|
1063
Ziff Davis
ZD
$1.94B
| $6.04M | ﹤0.01% |
105,703
-90
| -0.1% | -$5.01K |
|
|
ALX
1064
Alexander's
ALX
$1.39B
| $6.02M | ﹤0.01% |
13,181
-1,141
| -8% | -$514K |
|
|
RBS.PRS.CL
1065
DELISTED
The Royal Bank Of Scotland Group
RBS.PRS.CL
| $5.99M | ﹤0.01% |
239,438
-98,000
| -29% | -$2.46M |
|
|
KATE
1066
DELISTED
Kate Spade & Company
KATE
| $5.99M | ﹤0.01% |
179,358
+17,247
| +11% | +$546K |
|
|
FSL
1067
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
| $5.99M | ﹤0.01% |
146,863
+96,915
| +194% | +$3.34M |
|
|
ACH
1068
Accendra Health
ACH
$247M
| $5.97M | ﹤0.01% |
176,387
+150,383
| +578% | +$5.24M |
|
1069
Prestige Consumer Healthcare
PBH
$2.42B
| $5.96M | ﹤0.01% |
139,002
-23,068
| -14% | -$879K |
|
1070
American States Water
AWR
$3.38B
| $5.95M | ﹤0.01% |
149,148
-11,774
| -7% | -$468K |
|
|
VR
1071
DELISTED
Validus Hold Ltd
VR
| $5.9M | ﹤0.01% |
140,036
-28,109
| -17% | -$1.16M |
|
1072
Flowers Foods
FLO
$1.65B
| $5.89M | ﹤0.01% |
259,201
+18,273
| +8% | +$379K |
|
1073
Oaktree Specialty Lending
OCSL
$1.04B
| $5.86M | ﹤0.01% |
267,680
+47,363
| +21% | +$1.06M |
|
|
PFNX
1074
DELISTED
Pfenex Inc.
PFNX
| $5.83M | ﹤0.01% |
365,437
-64,379
| -15% | -$710K |
|
1075
Marcus & Millichap
MMI
$1.18B
| $5.8M | ﹤0.01% |
154,738
+38,484
| +33% | +$1.37M |
|
Similar funds
BA
BIM
BJ
IC
EAM
MFS
CIM
KAM
BlackRock Group's Q1 2015 Portfolio in Review
As of Q1 2015, BlackRock Group held 2,978 positions worth $186B, down 0.68% from $187B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock Group's Q1 2015 filing shows 110 new, 1,386 increased, 1,151 reduced and 137 closed positions. Its largest new stake was iShares MSCI USA Size Factor ETF: 495,310 shares worth $33M. The largest sale was Allergan Inc, an estimated $591M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
- BlackRock Group's largest Q1 2015 buy was iShares MSCI USA Size Factor ETF: 495,310 shares worth $33M.
- BlackRock Group added most to Medtronic in Q1 2015, an estimated $296M increase.
- BlackRock Group's biggest Q1 2015 reduction was Freeport-McMoran, cutting an estimated $147M.
- BlackRock Group fully exited Allergan Inc in Q1 2015, selling an estimated $591M.
- BlackRock Group's ten largest holdings make up 14% of its $186B portfolio in Q1 2015.
- BlackRock Group opened 110 new positions and closed 137 in Q1 2015.
- BlackRock Group's portfolio value fell 0.68% quarter-over-quarter to $186B.
Based on BlackRock Group's 13F filing for Q1 2015, filed 13 May 2015.